| Matthew Walter Wilkening, MD | |
|
17 Riverside St Ste 101, Nashua, NH 03062-1383 | |
| (603) 883-0091 | |
| (603) 881-3739 |
| Full Name | Matthew Walter Wilkening |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 11 Years |
| Location | 17 Riverside St Ste 101, Nashua, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295174753 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Catholic Medical Center | Manchester, NH | Hospital |
| Elliot Hospital | Manchester, NH | Hospital |
| Parkland Medical Center | Derry, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Four Seasons Orthopaedic Center Pllc | 5193791804 | 41 |
News Archive
Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market over-the-counter (OTC) Cetirizine Cherry Syrup, 1mg/ml. Shipments will begin in the Company's fiscal first quarter 2011. Cherry joins the currently available grape flavor cetirizine syrup in Perrigo's product portfolio, giving patients a choice of store brand flavors.
USAID Administrator Rajiv Shah on Wednesday at the Food Security Investment Forum outlined U.S. plans for its food security partnership with Bangladesh as part of the Feed the Future initiative, the Daily Star reports. The goal of the two-day forum was "to help Bangladesh finalise a roadmap for future investments in food and agriculture," the publication writes (5/27).
Viji Santhakumar, an associate professor of molecular, cell and systems biology at the University of California, Riverside, has received funding from the National Institute of Neurological Disaster and Stroke of the National Institutes of Health to further pursue research on moderate concussive brain injury, which results from car accidents or sports-related concussions.
The Associated Press reports that the first estimate of health care's carbon footprint has found that the industry "emits less than its share of the gases that promote global warming, compared to its size in the economy."
The blood-thinning drug Warfarin tops the list of drug side-effects in Sweden. Patient sensitivity to Warfarin varies, which can lead to over-dosage and in certain cases to death.
› Verified 2 days ago
| Entity Name | Four Seasons Orthopaedic Center Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881772242 PECOS PAC ID: 5193791804 Enrollment ID: O20040903000533 |
News Archive
Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market over-the-counter (OTC) Cetirizine Cherry Syrup, 1mg/ml. Shipments will begin in the Company's fiscal first quarter 2011. Cherry joins the currently available grape flavor cetirizine syrup in Perrigo's product portfolio, giving patients a choice of store brand flavors.
USAID Administrator Rajiv Shah on Wednesday at the Food Security Investment Forum outlined U.S. plans for its food security partnership with Bangladesh as part of the Feed the Future initiative, the Daily Star reports. The goal of the two-day forum was "to help Bangladesh finalise a roadmap for future investments in food and agriculture," the publication writes (5/27).
Viji Santhakumar, an associate professor of molecular, cell and systems biology at the University of California, Riverside, has received funding from the National Institute of Neurological Disaster and Stroke of the National Institutes of Health to further pursue research on moderate concussive brain injury, which results from car accidents or sports-related concussions.
The Associated Press reports that the first estimate of health care's carbon footprint has found that the industry "emits less than its share of the gases that promote global warming, compared to its size in the economy."
The blood-thinning drug Warfarin tops the list of drug side-effects in Sweden. Patient sensitivity to Warfarin varies, which can lead to over-dosage and in certain cases to death.
› Verified 2 days ago
| Entity Name | Northeast Orthopaedic Alliance Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417724170 PECOS PAC ID: 5991149809 Enrollment ID: O20240223001001 |
News Archive
Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market over-the-counter (OTC) Cetirizine Cherry Syrup, 1mg/ml. Shipments will begin in the Company's fiscal first quarter 2011. Cherry joins the currently available grape flavor cetirizine syrup in Perrigo's product portfolio, giving patients a choice of store brand flavors.
USAID Administrator Rajiv Shah on Wednesday at the Food Security Investment Forum outlined U.S. plans for its food security partnership with Bangladesh as part of the Feed the Future initiative, the Daily Star reports. The goal of the two-day forum was "to help Bangladesh finalise a roadmap for future investments in food and agriculture," the publication writes (5/27).
Viji Santhakumar, an associate professor of molecular, cell and systems biology at the University of California, Riverside, has received funding from the National Institute of Neurological Disaster and Stroke of the National Institutes of Health to further pursue research on moderate concussive brain injury, which results from car accidents or sports-related concussions.
The Associated Press reports that the first estimate of health care's carbon footprint has found that the industry "emits less than its share of the gases that promote global warming, compared to its size in the economy."
The blood-thinning drug Warfarin tops the list of drug side-effects in Sweden. Patient sensitivity to Warfarin varies, which can lead to over-dosage and in certain cases to death.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Walter Wilkening, MD 17 Riverside St Ste 101, Nashua, NH 03062-1383 Ph: (603) 883-0091 | Matthew Walter Wilkening, MD 17 Riverside St Ste 101, Nashua, NH 03062-1383 Ph: (603) 883-0091 |
News Archive
Perrigo Company today announced that it has received final approval from the U.S. Food and Drug Administration to manufacture and market over-the-counter (OTC) Cetirizine Cherry Syrup, 1mg/ml. Shipments will begin in the Company's fiscal first quarter 2011. Cherry joins the currently available grape flavor cetirizine syrup in Perrigo's product portfolio, giving patients a choice of store brand flavors.
USAID Administrator Rajiv Shah on Wednesday at the Food Security Investment Forum outlined U.S. plans for its food security partnership with Bangladesh as part of the Feed the Future initiative, the Daily Star reports. The goal of the two-day forum was "to help Bangladesh finalise a roadmap for future investments in food and agriculture," the publication writes (5/27).
Viji Santhakumar, an associate professor of molecular, cell and systems biology at the University of California, Riverside, has received funding from the National Institute of Neurological Disaster and Stroke of the National Institutes of Health to further pursue research on moderate concussive brain injury, which results from car accidents or sports-related concussions.
The Associated Press reports that the first estimate of health care's carbon footprint has found that the industry "emits less than its share of the gases that promote global warming, compared to its size in the economy."
The blood-thinning drug Warfarin tops the list of drug side-effects in Sweden. Patient sensitivity to Warfarin varies, which can lead to over-dosage and in certain cases to death.
› Verified 2 days ago
Anand Padmanabha, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 17 Prospect St Ste N203, Nashua, NH 03060 Phone: 603-577-2663 Fax: 603-577-3366 | |
Christian Matthew Klare, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 17 Riverside St Ste 101, Nashua, NH 03062 Phone: 603-883-0091 Fax: 603-881-3739 | |
Daniel P Bouvier, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 17 Riverside St, Suite 101, Nashua, NH 03062 Phone: 603-883-0091 Fax: 603-881-3739 | |
David P Richards, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 172 Kinsley St, Nashua, NH 03060 Phone: 603-578-9363 Fax: 603-578-9539 | |
Dr. Albert Tom, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 168 Kinsley St, Nashua, NH 03060 Phone: 603-578-9363 Fax: 603-578-9539 | |
Bryan Bean, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 17 Riverside St Ste 101, Nashua, NH 03062 Phone: 603-883-0091 Fax: 603-881-3739 | |
Dr. Jason Benjamin Smoak, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2300 Southwood Dr, Nashua, NH 03063 Phone: 603-577-4000 |